Source
3 developments in the corpus
Latest
Everything in the corpus, newest first.
SEP 30, 2026 · JOURNAL ARTICLE
JAMA Cardiology
Importance Among patients with heart failure (HF) in contemporary US clinical practice, the burden of overlapping cardiovascular-kidney-metabolic (CKM) conditions and the associate
SEP 9, 2026 · JOURNAL ARTICLE
JAMA Cardiology
Prospective cohort study with multimodal imaging and biomarker endpoints showing no detectable arterial inflammation with ICIs or VEGFIs, directly addressing an important but incompletely resolved mechanistic question; limited by modest sample size and surrogate endpoints rather than hard clinical outcomes.
AUG 26, 2026 · JOURNAL ARTICLE
JAMA Cardiology
High-quality meta-analysis of 8 RCTs with 7434 patients and 37.9-month follow-up reporting hard clinical endpoints (stroke, major bleeding) with precise effect estimates and confidence intervals, demonstrating no superiority of LAAC over OAC and a higher ischemic stroke risk.